The search for mutations within Ret-protooncogene in Czech and Slovak families with medullary thyroid cancer (MTC).

被引：0
|
作者：
Mazura, I [1 ]
Bendlová, B [1 ]
Vcelak, J [1 ]
Nutsu-Mazura, F [1 ]
Neradilova, M [1 ]
Nemec, J [1 ]
机构：
[1] Charles Univ, Dept Anthropol & Human Genet, Prague, Czech Republic
来源：
FASEB JOURNAL | 1999年 / 13卷 / 07期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1481 / A1481
页数：1
相关论文
共 50 条
  • [31] Screening of six risk exons of the RET proto-oncogene in families with medullary thyroid carcinoma in the Czech Republic
    Jindrichová, S
    Vcelák, J
    Vlcek, P
    Neradilová, M
    Nemec, J
    Bendlová, B
    JOURNAL OF ENDOCRINOLOGY, 2004, 183 (02) : 257 - 265
  • [32] Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations
    Oczko-Wojciechowska, Malgorzata
    Swierniak, Michal
    Krajewska, Jolanta
    Kowalska, Malgorzata
    Kowal, Monika
    Stokowy, Tomasz
    Wojtas, Bartosz
    Rusinek, Dagmara
    Pawlaczek, Agnieszka
    Czarniecka, Agnieszka
    Szpak-Ulczok, Sylwia
    Gawlik, Tomasz
    Chmielik, Ewa
    Tyszkiewicz, Tomasz
    Nikiel, Barbara
    Lange, Dariusz
    Jarzab, Michal
    Wiench, Malgorzata
    Jarzab, Barbara
    SCIENTIFIC REPORTS, 2017, 7
  • [33] Routine screening for germline RET mutations is recommended for all patients with medullary thyroid cancer
    Diana L Learoyd
    Bruce G Robinson
    Nature Clinical Practice Endocrinology & Metabolism, 2009, 5 : 6 - 7
  • [34] Ret proto-oncogene mutations in the slovenian population of patients with medullary thyroid cancer
    Sara, Milicevic
    Damijan, Bergant
    Tina, Zagar
    Barbara, Peric
    ONKOLOGIJA, 2020, 24 (01) : 12 - 18
  • [35] Routine screening for germline RET mutations is recommended for all patients with medullary thyroid cancer
    Learoyd, Diana L.
    Robinson, Bruce G.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2009, 5 (01): : 6 - 7
  • [36] Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations
    Malgorzata Oczko-Wojciechowska
    Michal Swierniak
    Jolanta Krajewska
    Malgorzata Kowalska
    Monika Kowal
    Tomasz Stokowy
    Bartosz Wojtas
    Dagmara Rusinek
    Agnieszka Pawlaczek
    Agnieszka Czarniecka
    Sylwia Szpak-Ulczok
    Tomasz Gawlik
    Ewa Chmielik
    Tomasz Tyszkiewicz
    Barbara Nikiel
    Dariusz Lange
    Michal Jarzab
    Malgorzata Wiench
    Barbara Jarzab
    Scientific Reports, 7
  • [37] Timing and Ideal Patient for an Appropriate Search for Somatic RET Mutation in Medullary Thyroid Cancer
    Matrone, Antonio
    Prete, Alessandro
    Gambale, Carla
    Elisei, Rossella
    JCO PRECISION ONCOLOGY, 2024, 8
  • [38] Diversity of mutations in the RET proto-oncogene and its oncogenic mechanism in medullary thyroid cancer
    Hedayati, Mehdi
    Yeganeh, Marjan Zarif
    Sheikholeslami, Sara
    Afsari, Farinaz
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2016, 53 (04) : 217 - 227
  • [39] Germline homozygous mutations at codon 804 in the RET protooncogene in medullary thyroid carcinoma/multiple endocrine neoplasia type 2A patients
    Lesueur, F
    Cebrian, A
    Cranston, A
    Leyland, J
    Faid, TM
    Clements, MR
    Robledo, M
    Whittaker, J
    Ponder, BAJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (06): : 3454 - 3457
  • [40] A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A
    Berndt, I
    Reuter, M
    Saller, B
    Frank-Raue, K
    Groth, P
    Grussendorf, M
    Raue, F
    Ritter, MM
    Höppner, W
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03): : 770 - 774
12345